Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep767 | Pituitary: clinical | ECE2015

Response to pasireotide in an acromegalic patient with resistance to conventional medical treatment

Saenz Maria Sonia Gaztambide , Fernandez Pedro Gonzalez , Unanue Ihintza Larranaga , Rodriguez Maria Dolores Moure

Introduction: Surgery is the primary therapy in most acromelagic patients. When persistent disease is observed, adjuvant medical therapy is used. Pasireotide is a somatostatin analogue (SSA) not approved for acromegaly therapy yet, but with a potentially better response, given that it binds to four out of five somatostatin receptors.Materials and methods: We present the case of an acromegalic patient with resistance to many therapies and response to trea...

ea0056p1176 | Thyroid cancer | ECE2018

131I-MIBG as a treatment in medullary thyroid carcinoma with distant metastases.

Uriarte Nerea Utrilla , Fernandez Pedro Gonzalez , Figueruelo Alba Esteban , Herrero Marina Nevares , Sandi Javier Santamaria

Introduction and objectives: The strategies for therapy of metastatic medullary thyroid carcinoma (MTC) are limited. Although Tyrosine kinase inhibitors (TKI) seem to be the first-line treatment, we want to explore other possibilities. Metaiodobenzylguanidine (MIBG) is a guanethidine derivative, structurally similar to norepinephrine. It was developed as an imaging agent with 123I radiolabeling. MIBG localizes neuroendocrine tumors including MTC. We are investigatin...

ea0056p364 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Influence of HLA pattern on the age at onset of type 1 diabetes mellitus

Fernandez Pedro Gonzalez , Rubio Elsa Fernandez , Etxebarria Ines Urrutia , Frutos Teba Gonzalez , Machado Natalia Maruri , Gonzalez Luis Castano , Saenz Sonia Gaztambide

Aim: To determine, in type 1 diabetes mellitus (T1DM) patients, if there is any relationship between the age at onset and the number of HLA risk alleles for T1DM (DRB1*03 and DRB1*04).Methods: Retrospective study. We selected patients with T1DM diagnosis (pancreatic autoimmunity and insulin-dependent diabetes) and age at onset >15 years, identifying 275 subjects (59.6% men and 40.4% women), with a median age at onset of 31 years (interquartile range ...